Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

P-glycoprotein (P-gp) detoxifies cells by exporting hundreds of chemically unrelated toxins but has been implicated in multidrug resistance (MDR) in the treatment of cancers. Substrate promiscuity is a hallmark of P-gp activity, thus a structural description of poly-specific drug-binding is important for the rational design of anticancer drugs and MDR inhibitors. The x-ray structure of apo P-gp at 3.8 angstroms reveals an internal cavity of ∼6000 angstroms cubed with a 30 angstrom separation of the two nucleotide-binding domains. Two additional P-gp structures with cyclic peptide inhibitors demonstrate distinct drug-binding sites in the internal cavity capable of stereoselectivity that is based on hydrophobic and aromatic interactions. Apo and drug-bound P-gp structures have portals open to the cytoplasm and the inner leaflet of the lipid bilayer for drug entry. The inward-facing conformation represents an initial stage of the transport cycle that is competent for drug binding.

[1]  A. E. Senior,et al.  Involvement of the "occluded nucleotide conformation" of P-glycoprotein in the catalytic pathway. , 2005, Biochemistry.

[2]  M. Schumacher,et al.  Structural mechanisms of multidrug recognition and regulation by bacterial multidrug transcription factors , 2002, Molecular microbiology.

[3]  R. Brennan,et al.  Structural Basis of Multidrug Recognition by BmrR, a Transcription Activator of a Multidrug Transporter , 1999, Cell.

[4]  I. Pastan,et al.  Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state. , 1998, Biochemistry.

[5]  Geoffrey Chang,et al.  X-ray structure of EmrE supports dual topology model , 2007, Proceedings of the National Academy of Sciences.

[6]  C. Higgins,et al.  The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface. , 1997, Biochimica et biophysica acta.

[7]  K. Locher,et al.  Structure of an ABC transporter in complex with its binding protein , 2007, Nature.

[8]  F. Sharom ABC multidrug transporters: structure, function and role in chemoresistance. , 2008, Pharmacogenomics.

[9]  Jinhui Dong,et al.  Structural Basis of Energy Transduction in the Transport Cycle of MsbA , 2005, Science.

[10]  V. Ling,et al.  Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein. , 1997, European journal of biochemistry.

[11]  D. Rees,et al.  An Inward-Facing Conformation of a Putative Metal-Chelate-Type ABC Transporter , 2007, Science.

[12]  P. Gros,et al.  Large Scale Purification of Detergent-soluble P-glycoprotein fromPichia pastoris Cells and Characterization of Nucleotide Binding Properties of Wild-type, Walker A, and Walker B Mutant Proteins* , 1999, The Journal of Biological Chemistry.

[13]  R. Rosenfeld Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[14]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[15]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[16]  Stephan Wilkens,et al.  Nucleotide-induced Structural Changes in P-glycoprotein Observed by Electron Microscopy* , 2008, Journal of Biological Chemistry.

[17]  C. Higgins,et al.  Three-dimensional Structures of the Mammalian Multidrug Resistance P-glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding* , 2003, The Journal of Biological Chemistry.

[18]  Douglas C. Rees,et al.  The E. coli BtuCD Structure: A Framework for ABC Transporter Architecture and Mechanism , 2002, Science.

[19]  Stephen G. Aller Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2010 .

[20]  D. Clarke,et al.  Simultaneous Binding of Two Different Drugs in the Binding Pocket of the Human Multidrug Resistance P-glycoprotein* , 2003, Journal of Biological Chemistry.

[21]  Geoffrey Chang,et al.  Flexibility in the ABC transporter MsbA: Alternating access with a twist , 2007, Proceedings of the National Academy of Sciences.

[22]  Anna Seelig,et al.  Quantification and characterization of P-glycoprotein-substrate interactions. , 2006, Biochemistry.

[23]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[24]  I. Bosch,et al.  Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein. , 1997, Biochemistry.

[25]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[26]  F. Quiocho,et al.  Crystal structure of a catalytic intermediate of the maltose transporter , 2007, Nature.

[27]  A. di Pietro,et al.  Three-dimensional structure by cryo-electron microscopy of YvcC, an homodimeric ATP-binding cassette transporter from Bacillus subtilis. , 2002, Journal of molecular biology.

[28]  D. Clarke,et al.  Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket. , 2006, The Biochemical journal.

[29]  Satoshi Murakami,et al.  Crystal structure of bacterial multidrug efflux transporter AcrB , 2002, Nature.

[30]  R. Tampé,et al.  Structural and Functional Fingerprint of the Mitochondrial ATP-binding Cassette Transporter Mdl1 from Saccharomyces cerevisiae* , 2006, Journal of Biological Chemistry.

[31]  D. Clarke,et al.  Identification of Residues in the Drug-binding Site of Human P-glycoprotein Using a Thiol-reactive Substrate* , 1997, The Journal of Biological Chemistry.

[32]  P. Johnston,et al.  Molecular mechanisms of drug resistance , 2005, The Journal of pathology.

[33]  I. Pastan,et al.  Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. , 1990, The Journal of biological chemistry.

[34]  Peter B. Reiner,et al.  β‐Amyloid efflux mediated by p‐glycoprotein , 2001 .

[35]  L. Moore,et al.  The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity , 2001, Science.